

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | drug catabolic process (GO:0042737) | 6.49564852 |
| 2 | drug transmembrane transport (GO:0006855) | 6.27135272 |
| 3 | sulfate transmembrane transport (GO:1902358) | 6.10298643 |
| 4 | aminoglycoside antibiotic metabolic process (GO:0030647) | 6.08677339 |
| 5 | epoxygenase P450 pathway (GO:0019373) | 5.78723967 |
| 6 | drug transport (GO:0015893) | 5.78331851 |
| 7 | exogenous drug catabolic process (GO:0042738) | 5.64282737 |
| 8 | lipoprotein transport (GO:0042953) | 5.59201511 |
| 9 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.58509880 |
| 10 | urate metabolic process (GO:0046415) | 5.39477304 |
| 11 | plasma lipoprotein particle assembly (GO:0034377) | 5.37694171 |
| 12 | sulfate transport (GO:0008272) | 5.36369096 |
| 13 | intestinal absorption (GO:0050892) | 5.32703716 |
| 14 | flavonoid metabolic process (GO:0009812) | 5.30167302 |
| 15 | sulfur compound transport (GO:0072348) | 5.23654447 |
| 16 | regulation of cholesterol esterification (GO:0010872) | 5.18837149 |
| 17 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 5.14901304 |
| 18 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 5.14901304 |
| 19 | high-density lipoprotein particle remodeling (GO:0034375) | 4.83871839 |
| 20 | regulation of triglyceride catabolic process (GO:0010896) | 4.79514259 |
| 21 | protein-lipid complex assembly (GO:0065005) | 4.75291565 |
| 22 | organic cation transport (GO:0015695) | 4.71881502 |
| 23 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.71070929 |
| 24 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 4.63374962 |
| 25 | vitamin transmembrane transport (GO:0035461) | 4.61501248 |
| 26 | phospholipid efflux (GO:0033700) | 4.59137046 |
| 27 | renal absorption (GO:0070293) | 4.54049755 |
| 28 | NADH metabolic process (GO:0006734) | 4.52761069 |
| 29 | negative regulation of keratinocyte proliferation (GO:0010839) | 4.49737763 |
| 30 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.49373372 |
| 31 | protein-lipid complex remodeling (GO:0034368) | 4.44786849 |
| 32 | macromolecular complex remodeling (GO:0034367) | 4.44786849 |
| 33 | plasma lipoprotein particle remodeling (GO:0034369) | 4.44786849 |
| 34 | phosphate ion transport (GO:0006817) | 4.44064511 |
| 35 | actin filament depolymerization (GO:0030042) | 4.43411451 |
| 36 | bicarbonate transport (GO:0015701) | 4.42723439 |
| 37 | maintenance of gastrointestinal epithelium (GO:0030277) | 4.39863048 |
| 38 | intestinal epithelial cell development (GO:0060576) | 4.32140343 |
| 39 | excretion (GO:0007588) | 4.31290457 |
| 40 | oligosaccharide catabolic process (GO:0009313) | 4.29508033 |
| 41 | reverse cholesterol transport (GO:0043691) | 4.27782718 |
| 42 | phosphate ion homeostasis (GO:0055062) | 4.26103737 |
| 43 | trivalent inorganic anion homeostasis (GO:0072506) | 4.26103737 |
| 44 | cholesterol efflux (GO:0033344) | 4.21072010 |
| 45 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 4.20244642 |
| 46 | bile acid metabolic process (GO:0008206) | 4.19257442 |
| 47 | urea metabolic process (GO:0019627) | 4.16354644 |
| 48 | urea cycle (GO:0000050) | 4.08049252 |
| 49 | lipoprotein metabolic process (GO:0042157) | 4.07821969 |
| 50 | plasma lipoprotein particle organization (GO:0071827) | 4.07365298 |
| 51 | phosphate ion transmembrane transport (GO:0035435) | 4.05465489 |
| 52 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 4.04628978 |
| 53 | endocrine process (GO:0050886) | 4.04628978 |
| 54 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 4.04628978 |
| 55 | cytidine metabolic process (GO:0046087) | 4.03023130 |
| 56 | cytidine catabolic process (GO:0006216) | 4.03023130 |
| 57 | cytidine deamination (GO:0009972) | 4.03023130 |
| 58 | hormone catabolic process (GO:0042447) | 4.01841640 |
| 59 | angiotensin maturation (GO:0002003) | 4.01233434 |
| 60 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.99704858 |
| 61 | peptide catabolic process (GO:0043171) | 3.93802190 |
| 62 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.92048190 |
| 63 | modified amino acid transport (GO:0072337) | 3.86738574 |
| 64 | low-density lipoprotein particle remodeling (GO:0034374) | 3.85718832 |
| 65 | regulation of guanylate cyclase activity (GO:0031282) | 3.84782562 |
| 66 | diacylglycerol metabolic process (GO:0046339) | 3.83224807 |
| 67 | regulation of cholesterol homeostasis (GO:2000188) | 3.81284531 |
| 68 | protein-lipid complex subunit organization (GO:0071825) | 3.81226232 |
| 69 | renal system process involved in regulation of blood volume (GO:0001977) | 3.81220777 |
| 70 | cholesterol homeostasis (GO:0042632) | 3.78352585 |
| 71 | vitamin D metabolic process (GO:0042359) | 3.75633502 |
| 72 | sterol homeostasis (GO:0055092) | 3.75501488 |
| 73 | nitrogen cycle metabolic process (GO:0071941) | 3.75109976 |
| 74 | surfactant homeostasis (GO:0043129) | 3.73177830 |
| 75 | hepatocyte apoptotic process (GO:0097284) | 3.73001588 |
| 76 | ethanol oxidation (GO:0006069) | 3.70462161 |
| 77 | vitamin transport (GO:0051180) | 3.68203860 |
| 78 | regulation of protein activation cascade (GO:2000257) | 3.64391526 |
| 79 | glomerulus development (GO:0032835) | 3.60004467 |
| 80 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.59731193 |
| 81 | O-glycan processing (GO:0016266) | 3.59244566 |
| 82 | desmosome organization (GO:0002934) | 3.58693639 |
| 83 | glutathione biosynthetic process (GO:0006750) | 3.58636254 |
| 84 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.58620456 |
| 85 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.57473228 |
| 86 | transepithelial transport (GO:0070633) | 3.56101172 |
| 87 | regulation of complement activation (GO:0030449) | 3.53660326 |
| 88 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.50606368 |
| 89 | regulation of systemic arterial blood pressure (GO:0003073) | 3.49368779 |
| 90 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.48570095 |
| 91 | bile acid and bile salt transport (GO:0015721) | 3.47568365 |
| 92 | glycoside metabolic process (GO:0016137) | 3.44453697 |
| 93 | cGMP-mediated signaling (GO:0019934) | 3.41122142 |
| 94 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.40314784 |
| 95 | drinking behavior (GO:0042756) | 3.37956686 |
| 96 | glutathione derivative metabolic process (GO:1901685) | 3.37190778 |
| 97 | glutathione derivative biosynthetic process (GO:1901687) | 3.37190778 |
| 98 | regulation of cholesterol metabolic process (GO:0090181) | 3.36039128 |
| 99 | phospholipid homeostasis (GO:0055091) | 3.34835330 |
| 100 | arginine metabolic process (GO:0006525) | 3.31679959 |
| 101 | diol metabolic process (GO:0034311) | 3.29798836 |
| 102 | L-ascorbic acid metabolic process (GO:0019852) | 3.29539242 |
| 103 | heme transport (GO:0015886) | 3.28240197 |
| 104 | lysine catabolic process (GO:0006554) | 3.27194671 |
| 105 | lysine metabolic process (GO:0006553) | 3.27194671 |
| 106 | digestive system process (GO:0022600) | 3.24718040 |
| 107 | negative regulation of cholesterol transport (GO:0032375) | 3.23962442 |
| 108 | negative regulation of sterol transport (GO:0032372) | 3.23962442 |
| 109 | midgut development (GO:0007494) | 3.23891345 |
| 110 | regulation of vitamin metabolic process (GO:0030656) | 3.23643796 |
| 111 | cellular ketone body metabolic process (GO:0046950) | 3.23600113 |
| 112 | regulation of keratinocyte proliferation (GO:0010837) | 3.21801707 |
| 113 | fructose metabolic process (GO:0006000) | 3.20311740 |
| 114 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.18533431 |
| 115 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.17068145 |
| 116 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.17068145 |
| 117 | negative regulation of fibrinolysis (GO:0051918) | 3.16756451 |
| 118 | regulation of bile acid biosynthetic process (GO:0070857) | 3.14369703 |
| 119 | alkaloid metabolic process (GO:0009820) | 3.12873617 |
| 120 | positive regulation of lipid catabolic process (GO:0050996) | 3.10729048 |
| 121 | toxin transport (GO:1901998) | 3.10662910 |
| 122 | homocysteine metabolic process (GO:0050667) | 3.10240200 |
| 123 | response to hepatocyte growth factor (GO:0035728) | 3.09578466 |
| 124 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.09578466 |
| 125 | adhesion of symbiont to host cell (GO:0044650) | 3.09569011 |
| 126 | virion attachment to host cell (GO:0019062) | 3.09569011 |
| 127 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.09510017 |
| 128 | vitamin A metabolic process (GO:0006776) | 3.08861895 |
| 129 | neurotransmitter biosynthetic process (GO:0042136) | 3.08552498 |
| 130 | cellular response to vitamin D (GO:0071305) | 3.08332811 |
| 131 | lipid homeostasis (GO:0055088) | 3.08303342 |
| 132 | sulfur amino acid catabolic process (GO:0000098) | 3.07348435 |
| 133 | regulation of cellular extravasation (GO:0002691) | 3.07327464 |
| 134 | positive regulation of steroid metabolic process (GO:0045940) | 3.05678625 |
| 135 | cellular glucuronidation (GO:0052695) | 3.05659904 |
| 136 | regulation of cGMP biosynthetic process (GO:0030826) | 3.05333242 |
| 137 | transcytosis (GO:0045056) | 3.04315870 |
| 138 | uronic acid metabolic process (GO:0006063) | 3.03559347 |
| 139 | glucuronate metabolic process (GO:0019585) | 3.03559347 |
| 140 | peptide biosynthetic process (GO:0043043) | 3.03521031 |
| 141 | polyol transport (GO:0015791) | 3.02577350 |
| 142 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.02365013 |
| 143 | triglyceride homeostasis (GO:0070328) | 3.02086381 |
| 144 | acylglycerol homeostasis (GO:0055090) | 3.02086381 |
| 145 | quaternary ammonium group transport (GO:0015697) | 3.01983336 |
| 146 | adhesion of symbiont to host (GO:0044406) | 3.01254827 |
| 147 | short-chain fatty acid metabolic process (GO:0046459) | 3.00667445 |
| 148 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 2.98397080 |
| 149 | fat-soluble vitamin metabolic process (GO:0006775) | 2.98254444 |
| 150 | sphingoid metabolic process (GO:0046519) | 2.97487533 |
| 151 | negative regulation of blood coagulation (GO:0030195) | 2.97457908 |
| 152 | negative regulation of hemostasis (GO:1900047) | 2.97457908 |
| 153 | epithelial structure maintenance (GO:0010669) | 2.96955903 |
| 154 | cellular anion homeostasis (GO:0030002) | 2.94655723 |
| 155 | glutathione metabolic process (GO:0006749) | 2.93964622 |
| 156 | intestinal cholesterol absorption (GO:0030299) | 2.92671837 |
| 157 | cysteine metabolic process (GO:0006534) | 2.91962280 |
| 158 | negative regulation of coagulation (GO:0050819) | 2.91513757 |
| 159 | vitamin biosynthetic process (GO:0009110) | 2.91405972 |
| 160 | sulfation (GO:0051923) | 2.91062185 |
| 161 | sterol transport (GO:0015918) | 2.90488147 |
| 162 | cholesterol transport (GO:0030301) | 2.90488147 |
| 163 | chemical homeostasis within a tissue (GO:0048875) | 2.89794745 |
| 164 | nucleotide transmembrane transport (GO:1901679) | 2.88782091 |
| 165 | drug metabolic process (GO:0017144) | 2.88352787 |
| 166 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.87332725 |
| 167 | digestion (GO:0007586) | 2.86004559 |
| 168 | diterpenoid biosynthetic process (GO:0016102) | 2.83776449 |
| 169 | fucose metabolic process (GO:0006004) | 2.76466029 |
| 170 | ethanol metabolic process (GO:0006067) | 2.74527040 |
| 171 | striated muscle atrophy (GO:0014891) | 2.74073040 |
| 172 | positive regulation of digestive system process (GO:0060456) | 2.73670641 |
| 173 | membrane repolarization during action potential (GO:0086011) | 2.72172097 |
| 174 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.72057810 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.75906712 |
| 2 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 4.60529089 |
| 3 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.02844795 |
| 4 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 3.43730520 |
| 5 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.28348818 |
| 6 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 3.03173911 |
| 7 | GATA4_25053715_ChIP-Seq_YYC3_Human | 3.01390057 |
| 8 | * SOX2_20726797_ChIP-Seq_SW620_Human | 2.99061511 |
| 9 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.83469501 |
| 10 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.72476859 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.72222504 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.71970741 |
| 13 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.64179043 |
| 14 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.55313592 |
| 15 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.54364326 |
| 16 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.49115076 |
| 17 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.09440477 |
| 18 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.94176434 |
| 19 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.93432968 |
| 20 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.83979495 |
| 21 | VDR_22108803_ChIP-Seq_LS180_Human | 1.81392452 |
| 22 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.74730513 |
| 23 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.66330652 |
| 24 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.65884828 |
| 25 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.65562746 |
| 26 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.64856499 |
| 27 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.63315656 |
| 28 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.63159284 |
| 29 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.61788282 |
| 30 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.60715719 |
| 31 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.60218030 |
| 32 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.58879295 |
| 33 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.56960338 |
| 34 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.56864810 |
| 35 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.56289897 |
| 36 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.50106613 |
| 37 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.47297590 |
| 38 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.45016506 |
| 39 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.44991224 |
| 40 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.44832271 |
| 41 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.43139843 |
| 42 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.43124322 |
| 43 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.38992432 |
| 44 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.38374094 |
| 45 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.35241759 |
| 46 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.34815080 |
| 47 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.33846439 |
| 48 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.30886498 |
| 49 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.30321831 |
| 50 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.29138703 |
| 51 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.29105641 |
| 52 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.26195879 |
| 53 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.24597202 |
| 54 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.24327860 |
| 55 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.21219260 |
| 56 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.21053134 |
| 57 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.21035278 |
| 58 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.20318276 |
| 59 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.18937968 |
| 60 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.17116418 |
| 61 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.16871477 |
| 62 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.16686548 |
| 63 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.16431120 |
| 64 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.16295950 |
| 65 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.15475573 |
| 66 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.15475573 |
| 67 | CJUN_26792858_Chip-Seq_BT549_Human | 1.15353520 |
| 68 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.14478974 |
| 69 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.13700499 |
| 70 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.13509674 |
| 71 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.13417113 |
| 72 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.10892481 |
| 73 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.10732422 |
| 74 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.10392096 |
| 75 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.09643422 |
| 76 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.09371028 |
| 77 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.09072887 |
| 78 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.08621154 |
| 79 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.07889537 |
| 80 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.07255874 |
| 81 | RXR_22108803_ChIP-Seq_LS180_Human | 1.04332462 |
| 82 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.04250031 |
| 83 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.02265234 |
| 84 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.02265234 |
| 85 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.00654252 |
| 86 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.00287626 |
| 87 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.98924229 |
| 88 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.98893051 |
| 89 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98866519 |
| 90 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.97953340 |
| 91 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.95882102 |
| 92 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.95670819 |
| 93 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.94767418 |
| 94 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.92176032 |
| 95 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.91679686 |
| 96 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.89837105 |
| 97 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.89490971 |
| 98 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89361178 |
| 99 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 0.88398630 |
| 100 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 0.88398630 |
| 101 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.88350862 |
| 102 | AR_20517297_ChIP-Seq_VCAP_Human | 0.87886130 |
| 103 | * NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.87747777 |
| 104 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87516580 |
| 105 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.87515227 |
| 106 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.87084836 |
| 107 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.86607159 |
| 108 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.86593794 |
| 109 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.86012325 |
| 110 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.85033734 |
| 111 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.84864598 |
| 112 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.83894999 |
| 113 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.83692823 |
| 114 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.83167750 |
| 115 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.83066250 |
| 116 | * PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.82679536 |
| 117 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.82236013 |
| 118 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.81762143 |
| 119 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.81632939 |
| 120 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.81307815 |
| 121 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.81160908 |
| 122 | * CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.81030361 |
| 123 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.81014441 |
| 124 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.80395482 |
| 125 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.80207211 |
| 126 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.79630834 |
| 127 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.79561769 |
| 128 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.79510261 |
| 129 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.79132599 |
| 130 | ATF3_27146783_Chip-Seq_COLON_Human | 0.78874789 |
| 131 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.78733227 |
| 132 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.78284579 |
| 133 | GATA1_22025678_ChIP-Seq_K562_Human | 0.77778222 |
| 134 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.77683844 |
| 135 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.77452387 |
| 136 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.77448715 |
| 137 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.77310411 |
| 138 | NCOR_22424771_ChIP-Seq_293T_Human | 0.76344949 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.37060524 |
| 2 | MP0003878_abnormal_ear_physiology | 4.63985695 |
| 3 | MP0005377_hearing/vestibular/ear_phenot | 4.63985695 |
| 4 | MP0010234_abnormal_vibrissa_follicle | 4.26871773 |
| 5 | MP0004264_abnormal_extraembryonic_tissu | 3.73685223 |
| 6 | MP0004043_abnormal_pH_regulation | 3.73094796 |
| 7 | MP0004019_abnormal_vitamin_homeostasis | 3.54287350 |
| 8 | MP0009840_abnormal_foam_cell | 3.39320309 |
| 9 | MP0000462_abnormal_digestive_system | 2.99246974 |
| 10 | MP0001666_abnormal_nutrient_absorption | 2.94190093 |
| 11 | MP0002822_catalepsy | 2.74004296 |
| 12 | MP0008875_abnormal_xenobiotic_pharmacok | 2.60485311 |
| 13 | MP0008004_abnormal_stomach_pH | 2.58864543 |
| 14 | MP0002138_abnormal_hepatobiliary_system | 2.58859995 |
| 15 | MP0001765_abnormal_ion_homeostasis | 2.54786919 |
| 16 | MP0003866_abnormal_defecation | 2.50115257 |
| 17 | MP0001873_stomach_inflammation | 2.48488968 |
| 18 | MP0002139_abnormal_hepatobiliary_system | 2.45068548 |
| 19 | MP0009643_abnormal_urine_homeostasis | 2.41209079 |
| 20 | MP0005085_abnormal_gallbladder_physiolo | 2.36941331 |
| 21 | MP0001663_abnormal_digestive_system | 2.27243567 |
| 22 | MP0005381_digestive/alimentary_phenotyp | 2.21537158 |
| 23 | MP0003252_abnormal_bile_duct | 2.18702075 |
| 24 | MP0003283_abnormal_digestive_organ | 2.12639244 |
| 25 | MP0000538_abnormal_urinary_bladder | 2.12476030 |
| 26 | MP0003941_abnormal_skin_development | 2.03660290 |
| 27 | MP0002277_abnormal_respiratory_mucosa | 2.02061027 |
| 28 | MP0000490_abnormal_crypts_of | 2.00808774 |
| 29 | MP0005636_abnormal_mineral_homeostasis | 1.98566504 |
| 30 | MP0005332_abnormal_amino_acid | 1.97874477 |
| 31 | MP0001664_abnormal_digestion | 1.95732278 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.92507704 |
| 33 | MP0000566_synostosis | 1.92034088 |
| 34 | MP0004782_abnormal_surfactant_physiolog | 1.89862848 |
| 35 | MP0009379_abnormal_foot_pigmentation | 1.85955236 |
| 36 | MP0001756_abnormal_urination | 1.80887445 |
| 37 | MP0009697_abnormal_copulation | 1.80610916 |
| 38 | MP0002136_abnormal_kidney_physiology | 1.78980128 |
| 39 | MP0005167_abnormal_blood-brain_barrier | 1.68354596 |
| 40 | MP0003315_abnormal_perineum_morphology | 1.66354637 |
| 41 | MP0005084_abnormal_gallbladder_morpholo | 1.66038515 |
| 42 | MP0005365_abnormal_bile_salt | 1.63849353 |
| 43 | MP0004147_increased_porphyrin_level | 1.63626551 |
| 44 | MP0000477_abnormal_intestine_morphology | 1.58405942 |
| 45 | MP0003300_gastrointestinal_ulcer | 1.53367195 |
| 46 | MP0003191_abnormal_cellular_cholesterol | 1.53111543 |
| 47 | MP0005409_darkened_coat_color | 1.43943722 |
| 48 | MP0005451_abnormal_body_composition | 1.37980506 |
| 49 | MP0003718_maternal_effect | 1.36588301 |
| 50 | MP0002796_impaired_skin_barrier | 1.33991318 |
| 51 | MP0005257_abnormal_intraocular_pressure | 1.31761373 |
| 52 | MP0010386_abnormal_urinary_bladder | 1.29436162 |
| 53 | MP0000013_abnormal_adipose_tissue | 1.28515263 |
| 54 | MP0005310_abnormal_salivary_gland | 1.25708806 |
| 55 | MP0000678_abnormal_parathyroid_gland | 1.23823121 |
| 56 | MP0000537_abnormal_urethra_morphology | 1.22637581 |
| 57 | MP0002132_abnormal_respiratory_system | 1.16834048 |
| 58 | MP0000609_abnormal_liver_physiology | 1.15620943 |
| 59 | MP0009780_abnormal_chondrocyte_physiolo | 1.15200540 |
| 60 | MP0002876_abnormal_thyroid_physiology | 1.15154383 |
| 61 | MP0002098_abnormal_vibrissa_morphology | 1.07942465 |
| 62 | MP0000470_abnormal_stomach_morphology | 1.05174105 |
| 63 | MP0003183_abnormal_peptide_metabolism | 1.00511835 |
| 64 | MP0010368_abnormal_lymphatic_system | 0.99805787 |
| 65 | MP0005501_abnormal_skin_physiology | 0.96920877 |
| 66 | MP0003453_abnormal_keratinocyte_physiol | 0.96642849 |
| 67 | MP0001501_abnormal_sleep_pattern | 0.94880563 |
| 68 | MP0001958_emphysema | 0.93780344 |
| 69 | MP0003806_abnormal_nucleotide_metabolis | 0.93406678 |
| 70 | MP0004484_altered_response_of | 0.90435628 |
| 71 | MP0003950_abnormal_plasma_membrane | 0.88379673 |
| 72 | MP0005166_decreased_susceptibility_to | 0.86427172 |
| 73 | MP0005448_abnormal_energy_balance | 0.84272572 |
| 74 | MP0003868_abnormal_feces_composition | 0.83668036 |
| 75 | MP0010678_abnormal_skin_adnexa | 0.82637694 |
| 76 | MP0003693_abnormal_embryo_hatching | 0.82613507 |
| 77 | MP0005058_abnormal_lysosome_morphology | 0.79857431 |
| 78 | MP0003186_abnormal_redox_activity | 0.79811945 |
| 79 | MP0000613_abnormal_salivary_gland | 0.78137830 |
| 80 | MP0001849_ear_inflammation | 0.77675938 |
| 81 | MP0002971_abnormal_brown_adipose | 0.76425854 |
| 82 | MP0002163_abnormal_gland_morphology | 0.76242502 |
| 83 | MP0003879_abnormal_hair_cell | 0.71464183 |
| 84 | MP0003943_abnormal_hepatobiliary_system | 0.70449413 |
| 85 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.67970864 |
| 86 | MP0005535_abnormal_body_temperature | 0.67118126 |
| 87 | MP0009115_abnormal_fat_cell | 0.67029650 |
| 88 | MP0003953_abnormal_hormone_level | 0.66968741 |
| 89 | MP0001216_abnormal_epidermal_layer | 0.66240632 |
| 90 | MP0005395_other_phenotype | 0.65082358 |
| 91 | MP0005376_homeostasis/metabolism_phenot | 0.63299544 |
| 92 | MP0002928_abnormal_bile_duct | 0.62575152 |
| 93 | MP0003656_abnormal_erythrocyte_physiolo | 0.62533180 |
| 94 | MP0003195_calcinosis | 0.62207270 |
| 95 | MP0000598_abnormal_liver_morphology | 0.60653219 |
| 96 | MP0003724_increased_susceptibility_to | 0.59622546 |
| 97 | MP0000230_abnormal_systemic_arterial | 0.59146278 |
| 98 | MP0003638_abnormal_response/metabolism_ | 0.58654356 |
| 99 | MP0010329_abnormal_lipoprotein_level | 0.58324582 |
| 100 | MP0008469_abnormal_protein_level | 0.57898127 |
| 101 | MP0000762_abnormal_tongue_morphology | 0.57701262 |
| 102 | MP0005319_abnormal_enzyme/_coenzyme | 0.57416647 |
| 103 | MP0001845_abnormal_inflammatory_respons | 0.56831816 |
| 104 | MP0009764_decreased_sensitivity_to | 0.56671206 |
| 105 | MP0001661_extended_life_span | 0.54361143 |
| 106 | MP0009785_altered_susceptibility_to | 0.54190877 |
| 107 | MP0002078_abnormal_glucose_homeostasis | 0.53179062 |
| 108 | MP0005367_renal/urinary_system_phenotyp | 0.52423960 |
| 109 | MP0000516_abnormal_urinary_system | 0.52423960 |
| 110 | MP0006054_spinal_hemorrhage | 0.51896921 |
| 111 | MP0005408_hypopigmentation | 0.51621532 |
| 112 | MP0010352_gastrointestinal_tract_polyps | 0.51110046 |
| 113 | MP0008872_abnormal_physiological_respon | 0.50463832 |
| 114 | MP0001764_abnormal_homeostasis | 0.50044839 |
| 115 | MP0001346_abnormal_lacrimal_gland | 0.49069151 |
| 116 | MP0002896_abnormal_bone_mineralization | 0.49058764 |
| 117 | MP0002135_abnormal_kidney_morphology | 0.48900877 |
| 118 | MP0001188_hyperpigmentation | 0.48529253 |
| 119 | MP0002089_abnormal_postnatal_growth/wei | 0.48082264 |
| 120 | MP0009642_abnormal_blood_homeostasis | 0.46435616 |
| 121 | MP0000249_abnormal_blood_vessel | 0.46162912 |
| 122 | MP0000639_abnormal_adrenal_gland | 0.46035833 |
| 123 | MP0002118_abnormal_lipid_homeostasis | 0.45761148 |
| 124 | MP0005334_abnormal_fat_pad | 0.44649985 |
| 125 | MP0005023_abnormal_wound_healing | 0.44534413 |
| 126 | MP0001485_abnormal_pinna_reflex | 0.43991546 |
| 127 | MP0002166_altered_tumor_susceptibility | 0.42945417 |
| 128 | MP0005670_abnormal_white_adipose | 0.42674426 |
| 129 | MP0004947_skin_inflammation | 0.42359209 |
| 130 | MP0005666_abnormal_adipose_tissue | 0.41404341 |
| 131 | MP0005410_abnormal_fertilization | 0.40415015 |
| 132 | MP0009333_abnormal_splenocyte_physiolog | 0.40129827 |
| 133 | MP0000681_abnormal_thyroid_gland | 0.39979412 |
| 134 | MP0002160_abnormal_reproductive_system | 0.39575262 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperactive renin-angiotensin system (HP:0000841) | 7.80085791 |
| 2 | Metabolic alkalosis (HP:0200114) | 6.78976631 |
| 3 | Hypobetalipoproteinemia (HP:0003563) | 6.61908622 |
| 4 | Abnormality of chloride homeostasis (HP:0011422) | 6.55522922 |
| 5 | Fat malabsorption (HP:0002630) | 5.10131294 |
| 6 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.97607298 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.86956349 |
| 8 | Abnormality of renin-angiotensin system (HP:0000847) | 4.81025556 |
| 9 | Hyperaldosteronism (HP:0000859) | 4.62269960 |
| 10 | Acanthocytosis (HP:0001927) | 4.36727622 |
| 11 | Proximal tubulopathy (HP:0000114) | 4.34595231 |
| 12 | Hypomagnesemia (HP:0002917) | 4.32913492 |
| 13 | Hydroxyprolinuria (HP:0003080) | 4.32026077 |
| 14 | Abnormality of proline metabolism (HP:0010907) | 4.32026077 |
| 15 | Increased circulating renin level (HP:0000848) | 4.30726874 |
| 16 | Tetany (HP:0001281) | 4.20266404 |
| 17 | Abnormality of magnesium homeostasis (HP:0004921) | 4.17760115 |
| 18 | Ileus (HP:0002595) | 4.16793644 |
| 19 | Abnormality of renal excretion (HP:0011036) | 4.04849321 |
| 20 | Hypolipoproteinemia (HP:0010981) | 4.03823238 |
| 21 | Hypokalemic alkalosis (HP:0001949) | 4.00598511 |
| 22 | Systemic lupus erythematosus (HP:0002725) | 3.95656905 |
| 23 | Deep venous thrombosis (HP:0002625) | 3.93438166 |
| 24 | Gout (HP:0001997) | 3.93296744 |
| 25 | Alkalosis (HP:0001948) | 3.90903292 |
| 26 | Complement deficiency (HP:0004431) | 3.88645666 |
| 27 | Abnormal urine output (HP:0012590) | 3.88295667 |
| 28 | Polyuria (HP:0000103) | 3.82834268 |
| 29 | Malnutrition (HP:0004395) | 3.76606991 |
| 30 | Increased purine levels (HP:0004368) | 3.60985026 |
| 31 | Hyperuricemia (HP:0002149) | 3.60985026 |
| 32 | Osteomalacia (HP:0002749) | 3.59291346 |
| 33 | Steatorrhea (HP:0002570) | 3.58510738 |
| 34 | Pigmentary retinal degeneration (HP:0001146) | 3.46867345 |
| 35 | Glycosuria (HP:0003076) | 3.41471616 |
| 36 | Abnormality of urine glucose concentration (HP:0011016) | 3.41471616 |
| 37 | Dehydration (HP:0001944) | 3.40035205 |
| 38 | Focal segmental glomerulosclerosis (HP:0000097) | 3.36382575 |
| 39 | Xanthomatosis (HP:0000991) | 3.33989420 |
| 40 | Hypokalemia (HP:0002900) | 3.29296622 |
| 41 | Right ventricular cardiomyopathy (HP:0011663) | 3.24993990 |
| 42 | Intrahepatic cholestasis (HP:0001406) | 3.23030060 |
| 43 | Abnormality of purine metabolism (HP:0004352) | 3.18888441 |
| 44 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.18442626 |
| 45 | Abnormal tarsal ossification (HP:0008369) | 3.15157297 |
| 46 | Hyperglycinuria (HP:0003108) | 3.11247809 |
| 47 | Abnormality of carpal bone ossification (HP:0006257) | 3.10245730 |
| 48 | Renal salt wasting (HP:0000127) | 3.07080376 |
| 49 | Abnormality of complement system (HP:0005339) | 3.05372232 |
| 50 | Glomerulonephritis (HP:0000099) | 3.04860097 |
| 51 | Congenital sensorineural hearing impairment (HP:0008527) | 3.03003694 |
| 52 | Glomerulosclerosis (HP:0000096) | 3.01618246 |
| 53 | Abnormal drinking behavior (HP:0030082) | 3.00942514 |
| 54 | Polydipsia (HP:0001959) | 3.00942514 |
| 55 | Hypophosphatemic rickets (HP:0004912) | 2.99469221 |
| 56 | Flat acetabular roof (HP:0003180) | 2.99343557 |
| 57 | Prolonged partial thromboplastin time (HP:0003645) | 2.96302864 |
| 58 | Thin bony cortex (HP:0002753) | 2.96058445 |
| 59 | Cupped ribs (HP:0000887) | 2.95618073 |
| 60 | Hypercalciuria (HP:0002150) | 2.87049527 |
| 61 | Generalized aminoaciduria (HP:0002909) | 2.83252681 |
| 62 | Abdominal distention (HP:0003270) | 2.82899575 |
| 63 | Widely patent fontanelles and sutures (HP:0004492) | 2.81844395 |
| 64 | Decreased circulating renin level (HP:0003351) | 2.78392358 |
| 65 | Epidermoid cyst (HP:0200040) | 2.77865740 |
| 66 | Abnormality of potassium homeostasis (HP:0011042) | 2.76782953 |
| 67 | Vacuolated lymphocytes (HP:0001922) | 2.76151687 |
| 68 | Chronic diarrhea (HP:0002028) | 2.64438516 |
| 69 | Hyperphosphaturia (HP:0003109) | 2.60851581 |
| 70 | Abnormal urine phosphate concentration (HP:0012599) | 2.57570009 |
| 71 | Hyperammonemia (HP:0001987) | 2.54782599 |
| 72 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.52190061 |
| 73 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.49083153 |
| 74 | Hyponatremia (HP:0002902) | 2.48648835 |
| 75 | Delayed epiphyseal ossification (HP:0002663) | 2.47465311 |
| 76 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.36662371 |
| 77 | Abnormality of vitamin B metabolism (HP:0004340) | 2.35880909 |
| 78 | Abnormal hand bone ossification (HP:0010660) | 2.33529617 |
| 79 | Hemorrhage of the eye (HP:0011885) | 2.30971391 |
| 80 | Abnormal biliary tract morphology (HP:0012440) | 2.30247417 |
| 81 | Megaloblastic anemia (HP:0001889) | 2.29893564 |
| 82 | Hypoglycemic coma (HP:0001325) | 2.29820152 |
| 83 | Abnormality of nucleobase metabolism (HP:0010932) | 2.27562212 |
| 84 | Pustule (HP:0200039) | 2.26593880 |
| 85 | Renal tubular acidosis (HP:0001947) | 2.25471110 |
| 86 | Hyperlipoproteinemia (HP:0010980) | 2.22211485 |
| 87 | Villous atrophy (HP:0011473) | 2.21366200 |
| 88 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.21366200 |
| 89 | Gonadal dysgenesis (HP:0000133) | 2.20903877 |
| 90 | Hypotension (HP:0002615) | 2.20569340 |
| 91 | Spontaneous abortion (HP:0005268) | 2.20502121 |
| 92 | Abnormality of the 1st metacarpal (HP:0010009) | 2.19222014 |
| 93 | Vascular calcification (HP:0004934) | 2.18989887 |
| 94 | Enlarged epiphyses (HP:0010580) | 2.17495823 |
| 95 | Hypophosphatemia (HP:0002148) | 2.16704079 |
| 96 | Abnormal ossification of hand bones (HP:0005921) | 2.15557311 |
| 97 | Nephrolithiasis (HP:0000787) | 2.14078464 |
| 98 | Poikilocytosis (HP:0004447) | 2.13823818 |
| 99 | Wide cranial sutures (HP:0010537) | 2.13680511 |
| 100 | Joint hemorrhage (HP:0005261) | 2.12874390 |
| 101 | Abnormality of sodium homeostasis (HP:0010931) | 2.11317371 |
| 102 | Conjugated hyperbilirubinemia (HP:0002908) | 2.10348140 |
| 103 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.09851691 |
| 104 | Dicarboxylic aciduria (HP:0003215) | 2.09851691 |
| 105 | Confusion (HP:0001289) | 2.07901624 |
| 106 | Cheilitis (HP:0100825) | 2.07615493 |
| 107 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.05173913 |
| 108 | Abnormality of glycine metabolism (HP:0010895) | 2.04466152 |
| 109 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.04466152 |
| 110 | Metaphyseal irregularity (HP:0003025) | 2.03735396 |
| 111 | Nausea (HP:0002018) | 2.02323382 |
| 112 | Abnormal foot bone ossification (HP:0010675) | 2.02035006 |
| 113 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.01316723 |
| 114 | Hyperphosphatemia (HP:0002905) | 2.00821055 |
| 115 | Hypoalphalipoproteinemia (HP:0003233) | 1.98829618 |
| 116 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.97914099 |
| 117 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.97244780 |
| 118 | Neonatal short-limb short stature (HP:0008921) | 1.97148465 |
| 119 | Adrenal overactivity (HP:0002717) | 1.96469558 |
| 120 | Nephritis (HP:0000123) | 1.93409288 |
| 121 | Facial shape deformation (HP:0011334) | 1.92613719 |
| 122 | Potter facies (HP:0002009) | 1.92613719 |
| 123 | Metabolic acidosis (HP:0001942) | 1.92054704 |
| 124 | Shawl scrotum (HP:0000049) | 1.91079321 |
| 125 | Rectal prolapse (HP:0002035) | 1.90805180 |
| 126 | Pancreatitis (HP:0001733) | 1.90541686 |
| 127 | Abnormality of renal resorption (HP:0011038) | 1.90169149 |
| 128 | Abnormality of the nasal septum (HP:0000419) | 1.89483878 |
| 129 | Prostate neoplasm (HP:0100787) | 1.86229172 |
| 130 | Abnormality of the common coagulation pathway (HP:0010990) | 1.85209078 |
| 131 | Visceral angiomatosis (HP:0100761) | 1.84917574 |
| 132 | Tubular atrophy (HP:0000092) | 1.84864939 |
| 133 | Alveolar cell carcinoma (HP:0006519) | 1.82874305 |
| 134 | Hypercholesterolemia (HP:0003124) | 1.81206194 |
| 135 | Cardiovascular calcification (HP:0011915) | 1.80710164 |
| 136 | Autoimmune thrombocytopenia (HP:0001973) | 1.79096298 |
| 137 | Abnormality of the renal cortex (HP:0011035) | 1.77287747 |
| 138 | Renal cortical cysts (HP:0000803) | 1.76313313 |
| 139 | Rickets (HP:0002748) | 1.74744956 |
| 140 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.74457836 |
| 141 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.74365275 |
| 142 | Abnormality of the costochondral junction (HP:0000919) | 1.73231090 |
| 143 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.71948543 |
| 144 | Abnormality of vitamin metabolism (HP:0100508) | 1.71654579 |
| 145 | Symptomatic seizures (HP:0011145) | 1.71315930 |
| 146 | Ketoacidosis (HP:0001993) | 1.71311471 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 5.15953629 |
| 2 | MST1R | 4.98409452 |
| 3 | MST4 | 4.49654105 |
| 4 | PIK3CA | 4.10476180 |
| 5 | WNK4 | 3.76678911 |
| 6 | STK38L | 3.70652785 |
| 7 | WNK3 | 3.63107504 |
| 8 | LMTK2 | 3.53573098 |
| 9 | OXSR1 | 3.28879321 |
| 10 | FRK | 3.26358086 |
| 11 | TNIK | 2.58893732 |
| 12 | NUAK1 | 2.57435728 |
| 13 | BRSK2 | 2.47823073 |
| 14 | FGFR3 | 2.46728800 |
| 15 | EPHB2 | 2.44529600 |
| 16 | MAP2K2 | 2.38579270 |
| 17 | NLK | 2.38486462 |
| 18 | PRKG2 | 2.33487239 |
| 19 | FGFR4 | 2.30407303 |
| 20 | PINK1 | 2.25005194 |
| 21 | EPHA2 | 2.18669408 |
| 22 | ERN1 | 2.11795615 |
| 23 | TTK | 2.05818481 |
| 24 | CAMKK2 | 1.96068158 |
| 25 | STK39 | 1.68518003 |
| 26 | MYLK | 1.61866908 |
| 27 | CDK8 | 1.46232315 |
| 28 | ZAK | 1.44171256 |
| 29 | LATS1 | 1.33548813 |
| 30 | ERBB4 | 1.33385020 |
| 31 | DMPK | 1.33312550 |
| 32 | MAP3K2 | 1.32377418 |
| 33 | NME1 | 1.30732069 |
| 34 | FGFR2 | 1.25716430 |
| 35 | TAOK3 | 1.21415432 |
| 36 | MET | 1.18190691 |
| 37 | MAP3K14 | 1.10565229 |
| 38 | BCR | 1.08905538 |
| 39 | IRAK3 | 1.07624536 |
| 40 | BRAF | 1.07080889 |
| 41 | TESK1 | 1.06330632 |
| 42 | INSRR | 1.04328906 |
| 43 | AKT3 | 1.02571572 |
| 44 | TBK1 | 0.98022715 |
| 45 | TGFBR2 | 0.90594181 |
| 46 | FGFR1 | 0.90162269 |
| 47 | PRKCI | 0.90139738 |
| 48 | STK10 | 0.89904191 |
| 49 | PIK3CG | 0.88427474 |
| 50 | GRK6 | 0.82360550 |
| 51 | PRKCE | 0.80760565 |
| 52 | TEC | 0.79049705 |
| 53 | MAP2K1 | 0.78893120 |
| 54 | MAP3K10 | 0.74938559 |
| 55 | PRKACG | 0.73483200 |
| 56 | TRIM28 | 0.73135048 |
| 57 | STK3 | 0.71701851 |
| 58 | GRK1 | 0.71064300 |
| 59 | PRKAA2 | 0.70748422 |
| 60 | TIE1 | 0.69848115 |
| 61 | BMPR1B | 0.69773346 |
| 62 | MAP3K12 | 0.68361194 |
| 63 | SIK3 | 0.65864471 |
| 64 | IKBKE | 0.65352763 |
| 65 | PDK2 | 0.65208624 |
| 66 | NEK9 | 0.65162898 |
| 67 | DAPK2 | 0.62726761 |
| 68 | PIM2 | 0.62460367 |
| 69 | WNK1 | 0.61917857 |
| 70 | PDK1 | 0.61680176 |
| 71 | TRPM7 | 0.61537268 |
| 72 | MAP3K8 | 0.61175163 |
| 73 | RIPK1 | 0.60595501 |
| 74 | STK38 | 0.60481992 |
| 75 | EIF2AK3 | 0.60049041 |
| 76 | MAPKAPK3 | 0.59751506 |
| 77 | PDPK1 | 0.58967699 |
| 78 | IRAK1 | 0.58671550 |
| 79 | PLK4 | 0.58539161 |
| 80 | SGK223 | 0.58201544 |
| 81 | SGK494 | 0.58201544 |
| 82 | MAPK15 | 0.57944669 |
| 83 | PAK4 | 0.57566072 |
| 84 | TAOK1 | 0.57487223 |
| 85 | ERBB3 | 0.55345969 |
| 86 | MAP3K7 | 0.54978084 |
| 87 | FER | 0.53382196 |
| 88 | ABL2 | 0.53270058 |
| 89 | BMPR2 | 0.52854936 |
| 90 | DDR2 | 0.52756814 |
| 91 | MAP2K4 | 0.52687434 |
| 92 | ARAF | 0.52675452 |
| 93 | MAPK11 | 0.51676538 |
| 94 | MATK | 0.51239124 |
| 95 | AURKB | 0.51028327 |
| 96 | PTK2 | 0.50917761 |
| 97 | ITK | 0.50742649 |
| 98 | MAP3K1 | 0.50462096 |
| 99 | BCKDK | 0.49582475 |
| 100 | SGK3 | 0.48953629 |
| 101 | PRKAA1 | 0.48888815 |
| 102 | CAMK2D | 0.47026359 |
| 103 | EIF2AK1 | 0.46394743 |
| 104 | CDK9 | 0.46176352 |
| 105 | SGK2 | 0.46051961 |
| 106 | MAP3K6 | 0.44978735 |
| 107 | MELK | 0.44302686 |
| 108 | ERBB2 | 0.44167804 |
| 109 | PRKD2 | 0.43615829 |
| 110 | MAP3K13 | 0.43437510 |
| 111 | MAP2K6 | 0.43133450 |
| 112 | PTK6 | 0.42111747 |
| 113 | PBK | 0.41652660 |
| 114 | MAP3K3 | 0.39887510 |
| 115 | MAP3K5 | 0.39747096 |
| 116 | GRK7 | 0.39453529 |
| 117 | STK24 | 0.38476017 |
| 118 | IGF1R | 0.37666653 |
| 119 | YES1 | 0.36287105 |
| 120 | RPS6KB1 | 0.35684056 |
| 121 | PRKCQ | 0.35476064 |
| 122 | PRKCA | 0.34936722 |
| 123 | AKT2 | 0.34592890 |
| 124 | CHEK2 | 0.32489508 |
| 125 | PRKG1 | 0.32107194 |
| 126 | CHUK | 0.32081965 |
| 127 | TESK2 | 0.30410523 |
| 128 | KSR2 | 0.30316335 |
| 129 | ROCK1 | 0.30068803 |
| 130 | SRC | 0.30002874 |
| 131 | PRKACA | 0.29679886 |
| 132 | CAMKK1 | 0.29525570 |
| 133 | TYK2 | 0.28428891 |
| 134 | CSNK1G1 | 0.27872044 |
| 135 | PRKCD | 0.26846594 |
| 136 | CSK | 0.26252590 |
| 137 | RET | 0.26024375 |
| 138 | BRD4 | 0.24936674 |
| 139 | CDK3 | 0.24410000 |
| 140 | PRKCZ | 0.24283300 |
| 141 | DAPK1 | 0.23564623 |
| 142 | CSNK1A1 | 0.22974465 |
| 143 | CAMK2G | 0.22435645 |
| 144 | MUSK | 0.21766477 |
| 145 | EIF2AK2 | 0.21430318 |
| 146 | CDK19 | 0.21241715 |
| 147 | RPS6KA2 | 0.21137005 |
| 148 | CAMK2B | 0.20027767 |
| 149 | BRSK1 | 0.18405657 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur metabolism_Homo sapiens_hsa00920 | 5.22519583 |
| 2 | Mineral absorption_Homo sapiens_hsa04978 | 4.17671464 |
| 3 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.29867058 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.85918636 |
| 5 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.67087413 |
| 6 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.57802973 |
| 7 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.32611395 |
| 8 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.26006897 |
| 9 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 2.24772838 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.21835068 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.16424472 |
| 12 | Histidine metabolism_Homo sapiens_hsa00340 | 2.13746301 |
| 13 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.12726193 |
| 14 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.98943716 |
| 15 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.96243476 |
| 16 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.91085543 |
| 17 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.83698319 |
| 18 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.80989309 |
| 19 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.80690452 |
| 20 | Bile secretion_Homo sapiens_hsa04976 | 1.80450984 |
| 21 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.77024653 |
| 22 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.76847287 |
| 23 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.75707329 |
| 24 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.74932350 |
| 25 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.71452367 |
| 26 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.66866540 |
| 27 | Other glycan degradation_Homo sapiens_hsa00511 | 1.64671854 |
| 28 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.58018387 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.55028277 |
| 30 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.49498798 |
| 31 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.49175621 |
| 32 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.46311742 |
| 33 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.43054341 |
| 34 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.38391176 |
| 35 | Galactose metabolism_Homo sapiens_hsa00052 | 1.38225303 |
| 36 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.33313854 |
| 37 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.30891917 |
| 38 | Sulfur relay system_Homo sapiens_hsa04122 | 1.30141526 |
| 39 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.30002458 |
| 40 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.27086660 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.26540513 |
| 42 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.25931546 |
| 43 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.21871373 |
| 44 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.21129300 |
| 45 | Peroxisome_Homo sapiens_hsa04146 | 1.20058293 |
| 46 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.17458150 |
| 47 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.16304805 |
| 48 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.13671220 |
| 49 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.06801427 |
| 50 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.03748640 |
| 51 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.01236995 |
| 52 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.94904247 |
| 53 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.91666966 |
| 54 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.88159320 |
| 55 | Tight junction_Homo sapiens_hsa04530 | 0.87530833 |
| 56 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.85829701 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83425424 |
| 58 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.80391081 |
| 59 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70533175 |
| 60 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.70396367 |
| 61 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.70008268 |
| 62 | Parkinsons disease_Homo sapiens_hsa05012 | 0.69792281 |
| 63 | Retinol metabolism_Homo sapiens_hsa00830 | 0.68902370 |
| 64 | Hepatitis C_Homo sapiens_hsa05160 | 0.62987301 |
| 65 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.62761309 |
| 66 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.60809261 |
| 67 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.60383679 |
| 68 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.60158308 |
| 69 | Carbon metabolism_Homo sapiens_hsa01200 | 0.59954500 |
| 70 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.59113571 |
| 71 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.59073631 |
| 72 | Metabolic pathways_Homo sapiens_hsa01100 | 0.59026081 |
| 73 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.57517126 |
| 74 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.57176193 |
| 75 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.56532352 |
| 76 | ABC transporters_Homo sapiens_hsa02010 | 0.55716900 |
| 77 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.55590535 |
| 78 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.55298616 |
| 79 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.54920720 |
| 80 | Alzheimers disease_Homo sapiens_hsa05010 | 0.52414043 |
| 81 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.51968283 |
| 82 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.51154332 |
| 83 | Adherens junction_Homo sapiens_hsa04520 | 0.50393924 |
| 84 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.47818460 |
| 85 | Renin secretion_Homo sapiens_hsa04924 | 0.47678739 |
| 86 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.45971773 |
| 87 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.44681401 |
| 88 | Bladder cancer_Homo sapiens_hsa05219 | 0.44370405 |
| 89 | Huntingtons disease_Homo sapiens_hsa05016 | 0.44156862 |
| 90 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.36466009 |
| 91 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.36354271 |
| 92 | Lysine degradation_Homo sapiens_hsa00310 | 0.34918388 |
| 93 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.34850397 |
| 94 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.34668571 |
| 95 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.34421104 |
| 96 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32261002 |
| 97 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.31781162 |
| 98 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.31352819 |
| 99 | Insulin resistance_Homo sapiens_hsa04931 | 0.29071391 |
| 100 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.29037757 |
| 101 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.28621588 |
| 102 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.28352944 |
| 103 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.24860819 |
| 104 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.24050781 |
| 105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.23869889 |
| 106 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.23605532 |
| 107 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.23017396 |
| 108 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.21961236 |
| 109 | Lysosome_Homo sapiens_hsa04142 | 0.21367963 |
| 110 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.20919613 |
| 111 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.20302587 |
| 112 | Salmonella infection_Homo sapiens_hsa05132 | 0.20041469 |
| 113 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.19854141 |
| 114 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.17145041 |
| 115 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.16921042 |
| 116 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.16752240 |
| 117 | Influenza A_Homo sapiens_hsa05164 | 0.16540918 |
| 118 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.15962064 |
| 119 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.15935970 |
| 120 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.14574108 |
| 121 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.13834665 |
| 122 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.12961771 |
| 123 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.11538896 |
| 124 | Pertussis_Homo sapiens_hsa05133 | 0.11321802 |
| 125 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.04142746 |
| 126 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | -0.0237209 |
| 127 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | -0.0166899 |
| 128 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0134517 |
| 129 | Asthma_Homo sapiens_hsa05310 | -0.0003833 |

